REGISTERED NUMBER: |
Financial Statements |
for the Year Ended 28 February 2023 |
for |
EPI-USE Labs Limited |
REGISTERED NUMBER: |
Financial Statements |
for the Year Ended 28 February 2023 |
for |
EPI-USE Labs Limited |
EPI-USE Labs Limited (Registered number: 09302382) |
Contents of the Financial Statements |
for the Year Ended 28 February 2023 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
EPI-USE Labs Limited |
Company Information |
for the Year Ended 28 February 2023 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
SENIOR STATUTORY AUDITOR: |
AUDITORS: |
Chartered Accountants and Chartered Tax Advisers |
2 Castle Business Village |
Station Road |
Hampton |
Middlesex |
TW12 2BX |
EPI-USE Labs Limited (Registered number: 09302382) |
Balance Sheet |
28 February 2023 |
28.2.23 | 28.2.22 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
CURRENT ASSETS |
Debtors | 5 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 6 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
PROVISIONS FOR LIABILITIES |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 7 |
Retained earnings | 8 |
SHAREHOLDERS' FUNDS |
In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
EPI-USE Labs Limited (Registered number: 09302382) |
Notes to the Financial Statements |
for the Year Ended 28 February 2023 |
1. | STATUTORY INFORMATION |
EPI-USE Labs Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
These financial statements have been prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention and are presented in sterling. |
Turnover |
Turnover represents net invoiced sales of goods and services, excluding value added tax, except in respect of service contracts where turnover is recognised upon completion. |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
Hire purchase and leasing commitments |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
EPI-USE Labs Limited (Registered number: 09302382) |
Notes to the Financial Statements - continued |
for the Year Ended 28 February 2023 |
2. | ACCOUNTING POLICIES - continued |
Tangible fixed assets |
Tangible fixed assets are depreciated at annual rates of 10% to 50% on cost. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
4. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 March 2022 |
Additions |
At 28 February 2023 |
DEPRECIATION |
At 1 March 2022 |
Charge for year |
At 28 February 2023 |
NET BOOK VALUE |
At 28 February 2023 |
At 28 February 2022 |
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
28.2.23 | 28.2.22 |
£ | £ |
Trade debtors |
Amounts owed by group undertakings |
Other debtors |
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
28.2.23 | 28.2.22 |
£ | £ |
Trade creditors |
Taxation and social security |
Other creditors |
EPI-USE Labs Limited (Registered number: 09302382) |
Notes to the Financial Statements - continued |
for the Year Ended 28 February 2023 |
7. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 28.2.23 | 28.2.22 |
value: | £ | £ |
Ordinary | £1 | 100 | 100 |
8. | RESERVES |
Retained |
earnings |
£ |
At 1 March 2022 |
Profit for the year |
At 28 February 2023 |
9. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
The Report of the Auditors was unqualified. |
for and on behalf of |
EPI-USE Labs Limited (Registered number: 09302382) |
Notes to the Financial Statements - continued |
for the Year Ended 28 February 2023 |
10. | RELATED PARTY DISCLOSURES |
During the year the company made sales to group companies as follows: |
2023 | 2022 |
£ | £ |
EULabs Limited | 659,104 | 1,166,512 |
EULabs BV | Nil | Nil |
Evolutio PS, LLC | Nil | 13,595 |
EPI-USE Limited | 387,169 | 35,070 |
EPI-USE Labs Limited AE | 27,052 | -150 |
G3G | 192,941 | 4,018 |
EPI-USE Africa (Pty) Ltd | 18,707 | Nil |
EPI-USE Labs LLC | 12,050 | Nil |
EPI-USE Labs ZA | 38,931 | Nil |
During the year the company made purchases from group companies as follows: |
2023 | 2022 |
£ | £ |
EPI-USE Africa (Pty) Ltd | 143,010 | 243,574 |
EPI-USE Labs ZA | 64,306 | Nil |
EPI-USE Limited | 49,176 | 62,777 |
G3G | 716,899 | 226,703 |
EPI-USE Labs LLC | 10,329 | 1,461 |
EPI-USE Labs GmbH | 173,233 | 53,519 |
EULabs Limited | 851,209 | 2,669,696 |
EPI-USE Switzerland | 2,172,185 | Nil |
EPI-USE America | 101,123 | Nil |
Evolutio PS, LLC | 5,460 | Nil |
At the balance sheet date the following amounts were due to group companies: |
2023 | 2022 |
£ | £ |
EULabs Limited | -15,856 | -303,771 |
EPI-USE Africa (Pty) Ltd | -27,399 | -95,810 |
EPI-USE Limited | -10,058 | -12,094 |
EPI-USE Labs LLC | -3,016 | -6,076 |
G3G | Nil | -21,822 |
EPI-USE America | -27,275 | Nil |
EPI-USE Labs GmbH | -14,816 | Nil |
EPI-USE Labs ZA | -7,758 | Nil |
EPI-USE Switzerland | -794,122 | Nil |
At the balance sheet date the following amounts were due from group companies: |
2023 | 2022 |
£ | £ |
EPI-USE Labs Limited (Registered number: 09302382) |
Notes to the Financial Statements - continued |
for the Year Ended 28 February 2023 |
EPI-USE Denmark ApS | Nil | Nil |
EPI-USE Iberia SL | Nil | Nil |
EPI-USE Limited | 47,983 | 74,279 |
G3G Limited | Nil | Nil |
EULabs BV | Nil | 580,534 |
Evolutio PS, LLC | Nil | Nil |
EPI-USE Labs Limited AE | 23,575 | Nil |
EPI-USE Labs ZA | 199 | Nil |
EPI-USE Labs LLC | 13,021 | Nil |
11. | ULTIMATE CONTROLLING PARTY |
The controlling party is EPI-USE Systems Limited. |
There are a number of shareholders in EPI-USE Systems Limited, none of whom hold a controlling interest in the company. |